Search Results

There are 3022 results for: content related to: Benefit-risk assessment: to quantify or not to quantify, that is the question

  1. Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 718–728, Kueiyu Joshua Lin, Luis A. García Rodríguez and Sonia Hernández-Díaz

    Article first published online : 27 MAY 2011, DOI: 10.1002/pds.2153

  2. Safety profile of oseltamivir during the 2009 influenza pandemic

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 532–543, Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

    Article first published online : 29 MAR 2011, DOI: 10.1002/pds.2136

  3. Incidence of interstitial lung disease in patients with mesothelioma in the west part of Japan

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 643–652, Shuko Nojiri, Kenichi Gemba, Keisuke Aoe, Katsuya Kato, Takuhiro Yamaguchi, Tsugumichi Sato, Kiyoshi Kubota and Takumi Kishimoto

    Article first published online : 18 MAR 2011, DOI: 10.1002/pds.2123

  4. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 567–582, Rolf Teschke, Wolfgang Schmidt-Taenzer and Albrecht Wolff

    Article first published online : 29 MAR 2011, DOI: 10.1002/pds.2127

  5. Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 838–848, John Paul Leombruno, Geoffrey C. Nguyen, Paul Grootendorst, David Juurlink and Tom Einarson

    Article first published online : 17 JUN 2011, DOI: 10.1002/pds.2132

  6. Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 497–505, Carlotta Franchi, Ugo Lucca, Mauro Tettamanti, Emma Riva, Ida Fortino, Angela Bortolotti, Luca Merlino, Luca Pasina and Alessandro Nobili

    Article first published online : 23 MAR 2011, DOI: 10.1002/pds.2124

  7. Drug prescriptions of adults with adolescent depression in a community sample

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 130–136, Aivar Päären, Lars von Knorring, Ulf Jonsson, Hannes Bohman, Gunilla Olsson and Anne-Liis von Knorring

    Article first published online : 26 APR 2011, DOI: 10.1002/pds.2120

  8. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 488–496, Alessandro Nobili, Carlotta Franchi, Luca Pasina, Mauro Tettamanti, Marta Baviera, Lara Monesi, Carla Roncaglioni, Emma Riva, Ugo Lucca, Angela Bortolotti, Ida Fortino and Luca Merlino

    Article first published online : 24 JAN 2011, DOI: 10.1002/pds.2108

  9. Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic “matrix design”

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 675–683, Jeremy A. Rassen, Daniel H. Solomon, Robert J. Glynn and Sebastian Schneeweiss

    Article first published online : 30 MAY 2011, DOI: 10.1002/pds.2121

  10. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 689–699, Vincent Lo Re III, Joseph K. Lim, Matthew Bidwell Goetz, Janet Tate, Harini Bathulapalli, Marina B. Klein, David Rimland, Maria C. Rodriguez-Barradas, Adeel A. Butt, Cynthia L. Gibert, Sheldon T. Brown, Farah Kidwai, Cynthia Brandt, Zachariah Dorey-Stein, K. Rajender Reddy and Amy C. Justice

    Article first published online : 27 MAY 2011, DOI: 10.1002/pds.2148

  11. Meta-analysis of interstitial pneumonia in studies evaluating iodine-131-labeled lipiodol for hepatocellular carcinoma using exact likelihood approach

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 9, September 2011, Pages: 956–963, Emmanuel Oger, Audrey Lavenu, Eric Bellissant, Etienne Garin and Elisabeth Polard

    Article first published online : 11 JUL 2011, DOI: 10.1002/pds.2177

  12. Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996–2006

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 729–738, Miia Artama, Mika Gissler, Heli Malm and Annukka Ritvanen

    Article first published online : 27 MAY 2011, DOI: 10.1002/pds.2159

  13. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 514–522, Johanna Jyrkkä, Hannes Enlund, Piia Lavikainen, Raimo Sulkava and Sirpa Hartikainen

    Article first published online : 9 FEB 2011, DOI: 10.1002/pds.2116

  14. Off-label prescribing patterns of antidepressants in children and adolescents

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 137–144, Euni Lee, Anna R. Teschemaker, Rosemary Johann-Liang, Gina Bazemore, Martin Yoon, Kye-Sik Shim, Marlon Daniel, Jerome Pittman and Anthony K. Wutoh

    Article first published online : 28 APR 2011, DOI: 10.1002/pds.2145

  15. Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 506–513, Fatemeh Chalabianloo, Aud Berstad, Jan Schjøtt, Bettina Riedel, Ågot Irgens and Erik Florvaag

    Article first published online : 29 MAR 2011, DOI: 10.1002/pds.2134

  16. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 747–753, Pernelle Noize, Haleh Bagheri, Geneviève Durrieu, Françoise Haramburu, Nicholas Moore, Patrick Giraud, Michel Galinier, Jacques Pourrat and Jean-Louis Montastruc

    Article first published online : 16 MAR 2011, DOI: 10.1002/pds.2128

  17. A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 598–607, Man Young Park, Dukyong Yoon, KiYoung Lee, Seok Yun Kang, Inwhee Park, Suk-Hyang Lee, Woojae Kim, Hye Jin Kam, Young-Ho Lee, Ju Han Kim and Rae Woong Park

    Article first published online : 6 APR 2011, DOI: 10.1002/pds.2139

  18. Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1088–1097, Andrea V. Margulis, Niteesh K. Choudhry, Colin R. Dormuth and Sebastian Schneeweiss

    Article first published online : 28 APR 2011, DOI: 10.1002/pds.2144

  19. Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005–2010

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 12, December 2011, Pages: 1269–1277, Benedikt Fischer, Wayne Jones, Murray Krahn and Jürgen Rehm

    Article first published online : 13 JUL 2011, DOI: 10.1002/pds.2190

  20. Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 700–708, Qian Li, Robert J. Glynn, Nancy A. Dreyer, Jun Liu, Helen Mogun and Soko Setoguchi

    Article first published online : 14 MAY 2011, DOI: 10.1002/pds.2146